medigraphic.com
ISSN 2500-7106 (Digital)
ISSN 0123-2576 (Impreso)
Medicina & Laboratorio

2013, Número 09-10

<< Anterior Siguiente >>

Medicina & Laboratorio 2013; 19 (09-10)


Tos y disnea de seis años de evolución en un adulto joven con melioidosis pulmonar crónica. Reporte de caso

Rosero ACH, Gómez G, Gutiérrez SOI

Idioma: Español
Referencias bibliográficas: 44
Paginas: 465-472
Archivo PDF: 1223.97 Kb.


RESUMEN

La melioidosis es una enfermedad infecciosa causada por una bacteria gram-negativa intracelular Burkholderia pseudomallei. Este microorganismo es un saprofito ambiental en regiones endémicas, algunas de ellas ubicadas probablemente en el territorio nacional y presenta alto riesgo de propagación como epidemia en zonas no endémicas. La melioidosis es una enfermedad clínicamente diversa, la mayoría de las infecciones son asintomáticas; sin embargo, si el paciente es sintomático, se puede clasificar como aguda o crónica según su persistencia. La presentación clínica más común es la afectación pulmonar y al diagnóstico predominan baciloscopias persistentemente negativas. Aquí se presenta un caso de un paciente con tos crónica, expectoración mucopurulenta, sudoración nocturna y disnea.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005; 18: 383-416.

  2. White NJ. Melioidosis. Lancet 2003; 361: 1715-1722.

  3. Dance DA. Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop 2000; 74: 159-168.

  4. Currie BJ, Fisher DA, Anstey NM, Jacups SP. Melioidosis: acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg 2000; 94: 301- 304.

  5. Dance DA. Melioidosis: the tip of the iceberg? Clin Microbiol Rev 1991; 4: 52-60.

  6. Rolim DB, Vilar DC, Sousa AQ, Miralles IS, de Oliveira DC, Harnett G, et al. Melioidosis, northeastern Brazil. Emerg Infect Dis 2005; 11: 1458-1460.

  7. Montufar F, Ochoa J, Ortega H, Franco L. Melioidosis in Colombia. An Emerging Disease. Chest 2011; 140: 753A.

  8. Mandell GL, Bennett JE, Dolin R. Mandell, Bennett, & Dolin: Principles and practice of infectious diseases (ed 6th). Philadelphia: Elsevier Churchill Livingstone; 2005.

  9. Stanton AT, Fletcher W. Melioidosis, a new disease of the tropics. Fourth Congress of the Far Eastern Association of Tropical Medicine. Batavia, 1921.

  10. Inglis TJ, Rolim DB, Sousa Ade Q. Melioidosis in the Americas. Am J Trop Med Hyg 2006; 75: 947-954.

  11. Currie BJ, Fisher DA, Howard DM, Burrow JN, Selvanayagam S, Snelling PL, et al. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop 2000; 74: 121-127.

  12. Dance DAB. Melioidosis. Rev Med Microbiol 1990; 1: 143-150.

  13. Leelarasamee A, Bovornkitti S. Melioidosis: review and update. Rev Infect Dis 1989; 11: 413-425.

  14. Green RN, Tuffnell PG. Laboratory acquired melioidosis. Am J Med 1968; 44: 599-605.

  15. Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, Rajanuwong A, Wuthiekanun V, et al. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis 1999; 29: 381-387.

  16. Vadivelu J, Puthucheary SD, Mifsud A, Drasar BS, Dance DA, Pitt TI. Ribotyping and DNA macrorestriction analysis of isolates of Burkholderia pseudomallei from cases of melioidosis in Malaysia. Trans R Soc Trop Med Hyg 1997; 91: 358-360.

  17. Chan KW, Jayaratnam FJ, Teo SK. Acute septicaemic melioidosis. A report of three fatal cases. Singapore Med J 1985; 26: 382-385.

  18. Lim MK, Tan EH, Soh CS, Chang TL. Burkholderia pseudomallei infection in the Singapore Armed Forces from 1987 to 1994--an epidemiological review. Ann Acad Med Singapore 1997; 26: 13-17.

  19. Currie BJ, Fisher DA, Howard DM, Burrow JN, Lo D, Selva-Nayagam S, et al. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 2000; 31: 981-986.

  20. Chaowagul W, White NJ, Dance DA, Wattanagoon Y, Naigowit P, Davis TM, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 1989; 159: 890-899.

  21. Warner J, Learoyd D, Pelowa D. Melioidosis in the Western Province of Papua New Guinea. In: Annual Scientific Meeting, Medical Society of Papua New Guinea, Port Moresby. 1998.

  22. Le Hello S, Currie BJ, Godoy D, Spratt BG, Mikulski M, Lacassin F, et al. Melioidosis in New Caledonia. Emerg Infect Dis 2005; 11: 1607-1609.

  23. González G, Mantilla WA, Rada R. Neumonía y osteomielitis por Burkholderia pseudomallei, reporte de un caso clínico. Rev Fac Med 2009; 17: 146-149.

  24. Dance DA. Melioidosis as an emerging global prob lem. Acta Trop 2000; 74: 115-119.

  25. Limmathurotsakul D, Chaowagul W, Chierakul W, Stepniewska K, Maharjan B, Wuthiekanun V, et al. Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect Dis 2006; 43: 979-986.

  26. Suputtamongkol Y, Chaowagul W, Chetchotisakd P, Lertpatanasuwun N, Intaranongpai S, Ruchutrakool T, et al. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis 1999; 29: 408-413.

  27. Sookpranee M, Lumbiganon P, Boonma P. Nosocomial contamination of Pseudomonas pseudomallei in the patients at Srinagarind Hospital. In: Melioidosis, Punyagupta S, Sirisanthana T, Stapatayavong B (Eds), Bangkok Medical Publisher, Bangkok 1989.

  28. Leelarasamee A. Melioidosis in Southeast Asia. Acta Trop 2000; 74: 129-132.

  29. Singapore Committee on Epidemic Diseases: Melioidosis in Singapore. Epidemiological News Bulletin 1995; 21:69.

  30. Currie BJ. Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions. Eur Respir J 2003; 22: 542-550.

  31. Osteraas GR, Hardman JM, Bass JW, Wilson C. Neonatal melioidosis. Am J Dis Child 1971; 122: 446-448.

  32. Kan SK, Kay RW. Melioidosis presenting as prostatitis-- a case report from Sabah. Trans R Soc Trop Med Hyg 1978; 72: 522-524.

  33. Morse LP, Moller CC, Harvey E, Ward L, Cheng AC, Carson PJ, et al. Prostatic abscess due to Burkholderia pseudomallei: 81 cases from a 19-year prospective melioidosis study. J Urol 2009; 182: 542-547; discussion 547.

  34. Steinmetz I, Stosiek P, Hergenrother D, Bar W. Melioidosis causing a mycotic aneurysm. Lancet 1996; 347: 1564-1565.

  35. Woods ML, 2nd, Currie BJ, Howard DM, Tierney A, Watson A, Anstey NM, et al. Neurological melioidosis: seven cases from the Northern Territory of Australia. Clin Infect Dis 1992; 15: 163-169.

  36. Anunnatsiri S, Chetchotisakd P, Kularbkaew C. Mycotic aneurysm in Northeast Thailand: the importance of Burkholderia pseudomallei as a causative pathogen. Clin Infect Dis 2008; 47: 1436-1439.

  37. Ruff MJ, Lamkin N, Jr., Braun J, Barnwell P. Melioidosis complicated by pericarditis. Chest 1976; 69: 227- 229.

  38. Weber DR, Douglass LE, Brundage WG, Stallkamp TC. Acute varieties of melioidosis occurring in U. S. soldiers in Vietnam. Am J Med 1969; 46: 234-244.

  39. Miralles IS, Maciel Mdo C, Angelo MR, Gondini MM, Frota LH, dos Reis CM, et al. Burkholderia pseudomallei: a case report of a human infection in Ceara, Brazil. Rev Inst Med Trop Sao Paulo 2004; 46: 51-54.

  40. Gilligan PH, Lum G, Vandamme P, Whitter S. Burkholderia, Stenotrophomonas, Ralstonia, Brevundimonas, Comamonas, Delftia, Pandoraea, and Acidovorax. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of clinical microbiology (ed 8th). Washington DC: ASM Press; 2003: 729-748.

  41. Jenney AW, Lum G, Fisher DA, Currie BJ. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int J Antimicrob Agents 2001; 17: 109-113.

  42. Smith MD, Wuthiekanun V, Walsh AL, White NJ. Susceptibility of Pseudomonas pseudomallei to some newer beta-lactam antibiotics and antibiotic combinations using time-kill studies. J Antimicrob Chemother 1994; 33: 145-149.

  43. Toohey M, Lew AE, Desmarchelier PM. Laboratory investigations of Australian isolates of ceftazidime resistant Pseudomonas pseudomallei. Antibiotic Special Interest Group (Australian Society of Microbiology). Newsletter 1994; 2: 1.

  44. Chaowagul W, Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, White NJ. A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis. Clin Infect Dis 1999; 29: 375-380.




2020     |     www.medigraphic.com